524663 — Bharat Immunologicals and Biologicals Balance Sheet
0.000.00%
Last trade - 00:00- IN₹1.01bn
- IN₹1.68bn
- IN₹446.09m
Annual balance sheet for Bharat Immunologicals and Biologicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 79.3 | 121 | 105 | 130 | 87.4 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 730 | 176 | 0.105 | 11.3 | 139 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 987 | 930 | 340 | 654 | 331 |
| Net Property, Plant And Equipment | 49.2 | 46.8 | 361 | 1,160 | 1,153 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,250 | 1,268 | 1,040 | 2,127 | 1,857 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 885 | 1,007 | 641 | 1,013 | 914 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 943 | 1,064 | 699 | 1,074 | 979 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 307 | 205 | 340 | 1,054 | 878 |
| Total Liabilities & Shareholders' Equity | 1,250 | 1,268 | 1,040 | 2,127 | 1,857 |
| Total Common Shares Outstanding |